Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-β1 in vascular smooth muscle

被引:42
|
作者
Siegert, A [1 ]
Ritz, E [1 ]
Orth, S [1 ]
Wagner, J [1 ]
机构
[1] Univ Heidelberg, Dept Nephrol, Ludolf Krehl Klin, D-69115 Heidelberg, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 05期
关键词
transforming growth factor; transforming growth factor receptor; vascular smooth muscle cells; angiotensin II;
D O I
10.1007/s001090050374
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Angiotensin II (Ang II) and transforming growth factor (TGF) beta(1) play a role in vascular remodeling in hypertension. In this process they may interact on various levels, including that of receptor regulation. This consideration prompted the present study on transcriptional regulation of TGF-beta receptors by Ang II and TGF-beta in vascular smooth muscle cells. Transcriptional expression of the components of the TGF-beta system was demonstrated for TGF-beta and for TGF-beta receptors I, II, and III. As measured by quantitative reverse transcriptase polymerase chain reaction, TGF-beta mRNA increased about 2. 4-fold in the presence of 40 pM exogenous TGF-beta. Ang II at 10(-6) M increased TGF-beta mRNA 2.5-fold compared to control cells (P < 0.05). Ang II also significantly increased TGF-beta protein concentration in the supernatant of confluent vascular smooth muscle cells. Ang II caused the induction of TGF-beta, but short-term experiments showed TGF-beta receptor II mRNA to be differentially regulated by Ang II and TGF-beta; while TGF-beta caused a 40% decrease in TGF-beta receptor II mRNA after 4 h (P < 0.05), Ang II caused an increase by about 70%. In contrast, both TGF-beta and Ang II increased TGF-beta receptor I mRNA to about 260% or 180% of controls (P < 0.05). TGF-beta effects were abrogated by coincubation with a TGF-beta neutralizing antibody, and Ang II effects were abrogated by losartan, an AT-1 receptor antagonist. Coincubation of Ang II with the TGF-beta neutralizing antibody did not inhibit the effect of Ang II, indicating that the short-term effects of Ang II on the expression of the TGF-beta receptors are not mediated via TGF-beta. Furthermore, Ang II stimulated DNA synthesis even in the presence of the TGF-beta neutralizing antibody. In conclusion, this study indicates (a) that in vascular smooth muscle TGF-beta receptors are regulated on the RNA level by TGF-beta and Ang II, and (b) that Ang II dependent regulation of TGF-beta receptors is at least partially independent of endogenous TGF-beta. Stimulation of the transcriptional expression of TGF-beta receptors by Ang II may increase sensitivity of vascular smooth muscle cells to TGF-beta.
引用
收藏
页码:437 / 445
页数:9
相关论文
共 50 条
  • [1] Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-β1 in vascular smooth muscle
    Antje Siegert
    Eberhard Ritz
    Stefan Orth
    J. Wagner
    [J]. Journal of Molecular Medicine, 1999, 77 : 437 - 445
  • [2] Abnormal regulation of transforming growth factor-β receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II
    Fukuda, N
    Hu, WY
    Kubo, A
    Endoh, M
    Kishioka, H
    Satoh, C
    Soma, M
    Izumi, Y
    Kanmatsuse, K
    [J]. HYPERTENSION, 1998, 31 (02) : 672 - 677
  • [3] Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells
    Fukuda, N
    Hu, WY
    Kubo, A
    Kishioka, H
    Satoh, C
    Soma, M
    Izumi, Y
    Kanmatsuse, K
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (02) : 191 - 198
  • [4] Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism
    Rodríguez-Vita, J
    Sánchez-López, E
    Esteban, V
    Rupérez, M
    Egido, J
    Ruiz-Ortega, M
    [J]. CIRCULATION, 2005, 111 (19) : 2509 - 2517
  • [5] Biological effects of transforming growth factor-β1 in idiopathic pulmonary fibrosis may be regulated by the activation of latent transforming growth factor-β1 and the differential expression of transforming growth factor-β receptors
    Khalil, N
    O'Connor, R
    Gold, LI
    Parekh, T
    Raghu, G
    [J]. CHEST, 2001, 120 (01) : 48S - 48S
  • [6] Transforming growth factor β1 regulation of vascular endothelial growth factor in pulmonary artery smooth muscle cells
    Clifford, R.
    Deacon, K.
    Corbett, L.
    Knox, A.
    [J]. THORAX, 2006, 61 : II19 - II21
  • [7] Involvement of transforming growth factor-β in regulation of calcium transients in diabetic vascular smooth muscle cells
    Sharma, K
    Deelman, L
    Madesh, M
    Kurz, B
    Ciccone, E
    Siva, S
    Hu, TS
    Zhu, YQ
    Wang, LW
    Henning, R
    Ma, XL
    Hajnoczky, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (06) : F1258 - F1270
  • [8] Expression of transforming growth factor-β1 and transforming growth factor-β receptors in hepatocellular carcinoma and dysplastic nodules
    Paik, SY
    Park, YN
    Kim, H
    Park, C
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 86 - 96
  • [9] Transforming growth factor-β dynamically regulates vascular smooth muscle differentiation in vivo
    Grainger, DJ
    Metcalfe, JC
    Grace, AA
    Mosedale, DE
    [J]. JOURNAL OF CELL SCIENCE, 1998, 111 : 2977 - 2988
  • [10] Regulation of transforming growth factor-β signaling and vascular diseases
    Miyazono, K
    [J]. CORNEA, 2002, 21 (07) : S48 - S53